70
Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In (www.propublica.org)
submitted 1 week ago by to c/politics@sh.itjust.works
3 comments fedilink hide all child comments
 

Alicia Jackson endorsed a key FDA policy change on hormone replacement therapies while holding at least $115,000 in stock in a company providing access to menopause treatments. Ethics experts called her endorsement an “obvious conflict of interest.”

you are viewing a single comment's thread
view the rest of the comments
[–] [S] 3 points 1 week ago (1 child)

But ethics experts called Jackson’s official endorsement of the warning removal “alarming” and an “obvious conflict of interest,” noting federal law prohibits government employees from participating “personally and substantially” in matters that could influence their personal finances — even making statements at a press conference or in a news release, as she also did.

  • permalink
  • fedilink
  • source
  • parent
  • hideshow 1 child comment
    •
  • [–] 3 points 1 week ago

    “personally and substantially”

    Very skeptical she did, considering the decision was reached before she was even in government.

    Ethics experts tend to be pretty worthless, because they just throw out buzzwords without actually analyzing the legal implications.

    Placing her on leave was the right call, but I doubt she'll get charged or punished in any substantial way (regardless of who is in office).

  • permalink
  • fedilink
  • source
  • parent